Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.


TSXV:NU.H - Post by User

Comment by lscfaon Jan 20, 2021 1:46pm
89 Views
Post# 32334805

RE:RE:RE:Valuation

RE:RE:RE:ValuationUsing a P/E ratio of 20x reflects a growth stock and using a gross margin of 50% may be considered conservative and thus reflecting risk.  


Edcando wrote: I'd assume this is based on yearly . So what does $50-$60 million a year look like? Also is there a formula of sorts based on Q revs? Like if Q1 is $10-$18 mil? Clearly one could X4 assuming no growth and use the $40 yearly figure, but just curious if there's a discount for unproven (because just one Q or a premium to allow for forward thinking on what should be growth. I have my own method (and numbers almost match up to yours but I like how this chart is laid out. Thanks for sharing 


<< Previous
Bullboard Posts
Next >>